ANTIPROLIFERATIVE AND SYNERGISTIC EFFECT OF INTERFERON ALPHA-2A, RETINOIDS AND THEIR ASSOCIATION IN ESTABLISHED HUMAN CANCER CELL-LINES

被引:40
作者
TOMA, S
MONTEGHIRFO, S
TASSO, P
NICOLO, G
SPADINI, N
PALUMBO, R
MOLINA, F
机构
[1] UNIV GENOA,INST CLIN & EXPTL ONCOL,GENOA,ITALY
[2] UNIV GENOA,INST CLIN DENT,GENOA,ITALY
[3] ADV BIOTECHNOL CTR,GENOA,ITALY
关键词
ALPHA-INTERFERON; 2A; RETINOIDS; SYNERGISTIC EFFECT;
D O I
10.1016/0304-3835(94)90014-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of 13-cis-retinoic acid (cRA) and all-trans-retinoic acid (tRA) used alone or in combination with interferon alpha-2a (alpha-IFN 2a) was tested on three established human cell lines: KB (epidermoid carcinoma of the oral cavity), SCC-25 (tongue squamous cell carcinoma) and MCF-7 (mammary carcinoma). Both retinoids significantly decreased cell proliferation (growth curves) and colony forming efficiency (CFE) in all cell lines, in a dose-dependent way (at a concentration ranging from 10(-5) to 10(-9) M) and differing from line to line, following the pattern: MCF-7 > SCC-25 > KB. Retinoids at any concentration (already at 10(-7) M) combined with alpha-IFN 2a (ranging from 100 to 500 IU/ml) were more effective in inhibiting cell proliferation than each of the two compounds alone. This was particularly evident with SCC-25 cells. Concerning MCF-7 cells, on the contrary, the effects produced by the association suggested a possible additive more than synergistic amplification of growth inhibition.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 21 条
[1]  
BARKLEY W, 1992, CANCER RES, V52, P6164
[2]   RETINOIDS IN CANCER PREVENTION AND THERAPY [J].
BOLLAG, W ;
HOLDENER, EE .
ANNALS OF ONCOLOGY, 1992, 3 (07) :513-526
[3]   THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY [J].
EVANS, RM .
SCIENCE, 1988, 240 (4854) :889-895
[4]   ANTIPROLIFERATIVE ACTIVITY OF RETINOIDS, INTERFERON ALPHA AND THEIR COMBINATION IN 5 HUMAN TRANSFORMED-CELL LINES [J].
FREY, JR ;
PECK, R ;
BOLLAG, W .
CANCER LETTERS, 1991, 57 (03) :223-227
[5]   EFFECTS OF INTERFERON AND RETINOIC ACID ON THE GROWTH AND DIFFERENTIATION OF CLONOGENIC LEUKEMIC-CELLS FROM ACUTE MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH RECOMBINANT LEUKOCYTE-ALPHA-A INTERFERON [J].
GALLAGHER, RE ;
LURIE, KJ ;
LEAVITT, RD ;
WIERNIK, PH .
LEUKEMIA RESEARCH, 1987, 11 (07) :609-+
[6]  
HEMMI H, 1987, BLOOD, V69, P501
[7]  
HIGUCHI T, 1991, CANCER RES, V51, P3958
[8]   LIGAND-SPECIFIC AND NON-SPECIFIC INVIVO MODULATION OF HUMAN EPIDERMAL CELLULAR RETINOIC ACID BINDING-PROTEIN (CRABP) [J].
HIRSCHELSCHOLZ, S ;
SIEGENTHALER, G ;
SAURAT, JH .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1989, 19 (02) :220-227
[9]   13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A - EFFECTIVE COMBINATION THERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE SKIN [J].
LIPPMAN, SM ;
PARKINSON, DR ;
ITRI, LM ;
WEBER, RS ;
SCHANTZ, SP ;
OTA, DM ;
SCHUSTERMAN, MA ;
KRAKOFF, IH ;
GUTTERMAN, JU ;
HONG, WK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04) :235-241
[10]   13-CIS-RETINOIC ACID PLUS INTERFERON ALPHA-2A - HIGHLY-ACTIVE SYSTEMIC THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE CERVIX [J].
LIPPMAN, SM ;
KAVANAGH, JJ ;
PAREDESESPINOZA, M ;
DELGADILLOMADRUENO, F ;
PAREDESCASILLAS, P ;
HONG, WK ;
HOLDENER, E ;
KRAKOFF, IH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04) :241-245